$5.64
arrow_drop_down3.33%Key Stats | |
---|---|
Open | $5.82 |
Prev. Close | $5.85 |
EPS | -1.34 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 5.79 | 5.82 |
52 Week Range | 2.28 | 6.69 |
Ratios | |
---|---|
EPS | -1.34 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Laboratory-Developed Tests (LDTs) World Market Forecast Report to 2028, with Coverage of the Effects of the FDA's New "Medical Devices: Laboratory Developed Tests" Rule, Passed in April 2024
Hematologic Malignancies Testing Markets, 2023-2033: Growing Utilization of Next-Generation Sequencing and AI, Increasing Partnerships, Alliances, and Business Expansions among Key Players
Agenus (AGEN) Tanks on Colorectal Cancer Study Interim Data - Zacks Investment Research
Arcutis (ARQT) Stock Rises 31% in the Past Month: Here's Why - Zacks Investment Research
Lisata (LSTA) Stock Rallies More Than 30% YTD: Here's Why - Zacks Investment Research
Athira (ATHA) Completes Dosing in Alzheimer's Study, Stock Up - Zacks Investment Research